Glyoxalase 1 expression is downregulated in preimplantation blastocysts of diabetic rabbits. (11th September 2019)

• Record Type: Journal Article
• Authors: Seeling, Tom; Haucke, Elisa; Navarrete Santos, Alexander; Grybel, Katarzyna J.; Gürke, Jacqueline; Pendzialek, S. Mareike; Schindler, Maria; Simm, Andreas; Navarrete Santos, Anne
• Other Names: Plemyashov Kirill guestEditor.; Nikitkina Elena guestEditor.
• Is Part Of: Reproduction in domestic animals. Volume 54(2019)Supplement 3
• Page Start: 4
• Page End: 11
• Publication Date: 2019-09-11
• Subjects: AGEs -- methylglyoxal, glyoxal -- insulin‐dependent diabetes mellitus -- metabolic stress -- post‐translational modification -- preimplantation embryo, glyoxalase 1; Animal breeding -- Periodicals; Veterinary pathology -- Periodicals; Livestock -- Breeding -- Periodicals; 636.082
• DOI: 10.1111/rda.13462
• Languages: English
• ISSNs: 0936-6768

Abstract

Abstract: In a diabetic pregnancy, an altered maternal metabolism led to increased formation of reactive α‐dicarbonyls such as glyoxal (GO) and methylglyoxal (MGO) in the reproductive organs and embryos. The enzyme glyoxalase (GLO) 1 detoxifies reactive α‐dicarbonyls thus protecting cells against malfunction or modifications of proteins by advanced glycated end products (AGEs). The aim of this study was to analyse the influence of a maternal insulin‐dependent diabetes mellitus (IDD) on GLO1 expression and activity in preimplantation embryos in vivo and human trophoblast cells (Ac‐1M88) in vitro. Maternal diabetes was induced in female rabbits by alloxan before conception and maintained during the preimplantation period. GLO1 expression and activity were investigated in 6‐day‐old blastocysts from healthy and diabetic rabbits. Furthermore, blastocysts and human trophoblast cells were exposed in vitro to hyperglycaemia, GO and MGO and analysed for GLO1 expression and activity. During gastrulation, GLO1 was expressed in all compartments of the rabbit blastocyst. Maternal diabetes decreased embryonic GLO1 protein amount by approx. 30 per cent whereas the enzymatic activity remained unchanged, indicating that the specific GLO1 activity increases along with metabolic changes. In in vitro cultured embryos, neither hyperglycaemia nor MGO and GO had an effect on GLO1 protein amount. In human trophoblast cells, a stimulating effect on the GLO1 expression was shown in the highest GO concentration, only. Our data show that maternal diabetes mellitus affects the specific activity of GLO1, indicating that GLO1 was post‐translationally modified due to changes in metabolic processes in the preimplantation embryos.